Potent Noncovalent Inhibitors of the Main Protease of SARS-CoV-2 from Molecular Sculpting of the Drug Perampanel Guided by Free Energy Perturbation Calculations

[Image: see text] Starting from our previous finding of 14 known drugs as inhibitors of the main protease (M(pro)) of SARS-CoV-2, the virus responsible for COVID-19, we have redesigned the weak hit perampanel to yield multiple noncovalent, nonpeptidic inhibitors with ca. 20 nM IC(50) values in a kin...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Chun-Hui, Stone, Elizabeth A., Deshmukh, Maya, Ippolito, Joseph A., Ghahremanpour, Mohammad M., Tirado-Rives, Julian, Spasov, Krasimir A., Zhang, Shuo, Takeo, Yuka, Kudalkar, Shalley N., Liang, Zhuobin, Isaacs, Farren, Lindenbach, Brett, Miller, Scott J., Anderson, Karen S., Jorgensen, William L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7931627/
https://www.ncbi.nlm.nih.gov/pubmed/33786375
http://dx.doi.org/10.1021/acscentsci.1c00039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7931627/
https://www.ncbi.nlm.nih.gov/pubmed/33786375
http://dx.doi.org/10.1021/acscentsci.1c00039

Ejemplares similares